Alpha Genesis Primate Research Center Continues European Expansion
A Dominant Bio-Research Presence Sought
YEMASSEE, S.C., July 11, 2018 (Newswire.com) - The Alpha Genesis Primate Research Center (AGPRC), the Research Division of Alpha Genesis Incorporated (AGI), is to take on additional European business commitments as the firm continues its expansion efforts on the continent. The move is expected to see AGI's European research business increase by over 75 percent to in excess of $4 million per annum over the next 18 months.
The main lines being considered are contract research projects with rhesus and cynomolgus macaques to accommodate explosive demand for work with nonhuman primates across Europe.
Our investment of over $2 million in staff and infrastructure has allowed us to make significant inroads across this highly competitive area.
Greg Westergaard, Ph.D., President and CEO
Furthermore, a number of AGI’s customers based in countries which support Big-Pharma such as France, Switzerland and the Netherlands will move an increased portion of their studies to AGI’s European outreach operation in 2019.
“This is an excellent opportunity to combine our talents and capitalise fully on the strength of Europe's Primate Research Markets and is a further step in our overall strategy to be a leading provider of primate research services for European Pharma. Our investment of over $2 million in staff and infrastructure has allowed us to make significant inroads across this highly competitive area, " commented Greg Westergaard, Ph.D., AGI President and CEO.
About AGI
Alpha Genesis is a leading life sciences company that provides primates and primate research services worldwide. With a mission to improve health and improve lives, Alpha Genesis delivers world-class solutions to the primate research community. To learn more about Alpha Genesis, visit www.alphagenesisinc.com and to learn more about the AGI Primate Research Center, visit www.primateresearch.com.
Source: Alpha Genesis Inc.
